Pharmacology Department

In 2011, among 32 African institutions selected as ANDI Centres of Excellence in health innovation, TBRI represented by pharmacology laboratory; was assigned as the
“ANDI Centre of Excellence on Anti-Trematodal R&D” 
by the Scientific and Technical Advisory Committee (STAC) of the African Network for Drugs and Diagnostics Innovation (ANDI).
 Drug Evaluation and Discovery Unit (DEDU), a subsidiary of pharmacology laboratory, will help in support and development of the activities of the center. The excellence centre is willing to collaborate with ANDI and with other African institutions with a focus on natural products, to complement research lines regarding the prevalent endemic diseases, and to increase our south-south collaboration to address specific health problems in the African continent. Moreover, it is looking for exchange visits between researchers with different capacities to help in building De Novo capacities, leverage existing ones through not only exchange of visits but also through training and execution of collaborative research projects.

The Head of Excellence Centre is Doctor Sanaa Botros, Professor of Pharmacology 

The activities of the centre include the following training programes:
1.    In vitro testing of antischistosomal activity of drugs/compounds (duration: one week). The programme includes; preparation of culture media, different concentrations of drugs/compounds, testing of worms’ viability/mortality, assessment and comparison of different compound potencies (LC50) in comparison to the reference compound. 
Fees: 1500 EGP for Egyptians/800US$ for non Egyptians                                                                                            
 The maximum available places are 5-7 persons/programme.

2.    In vivo testing of antischistosomal activity of drugs/compounds (duration: one week). The programme includes; animals handling, how to infect animals, routes of drug administration, perfusion of animals, worm and egg counts, percentage egg developmental stages (oogram pattern) and determination of ED50 of drugs/compounds.
Fees: 2000EGP for Egyptians /1200US$for non-Egyptians
The maximum available places are 5-7 persons/programme.

3.    Determination of acute and chronic toxicity of drugs/compounds (duration: one week). The programme includes; determination of the three cardinal parameters of mortality LD16, LD50 and LD84, acute and chronic toxicity using low doses of LD50, biochemical assessments and data interpretation.
Fees: 1500 EGP for Egyptians/500US$ for non-Egyptians
The maximum available places are 5-7 persons/programme.

4.     Isolation of hepatocytes and cytotoxicity of compounds (duration: one week). The programme includes; preparation of culture media and reagents, animals handling, perfusion of rat liver through portal vein, isolation of hepatocytes and cytotoxicity testing (MTT or SRB)/ compound.  
Fees: 3000EGP for Egyptians/ 2000US$ for non-Egyptians
The maximum available places are 3-5 persons/programme.

5.    Bioavailability of drugs/compounds (e.g Bioavailability of praziquantel (PZQ) & Paracetamol) (duration: one week). The programme includes; preparation of standards and reagents, extraction of drugs, sampEGP injection by HPLC and calculation of pharmacokinetic data.
Fees: 2500 EGP for Egyptians/ 1500US$ for non-Egyptians.
 The maximum available places are 3-5 persons/programme.

0 التعليقات: